FDA Approves Zynteglo for Patients with Beta-thalassemia Requiring Regular Blood Transfusions
August 17th 2022Zynteglo was approved for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions after safety and efficacy were demonstrated in clinical trials.
Read More
Addressing Language Barriers, Medication Therapy Management at Medicare Part D Outreach Clinics
August 17th 2022Rajul A. Patel, PharmD, PhD, director of the Medicare Part D Outreach Clinics at the University of the Pacific in Stockton, California, discusses his work providing drug savings advice to Medicare beneficiaries in diverse communities.
Watch